Skip to main content
. 2016 Aug 2;17:33. doi: 10.1186/s12903-016-0262-4

Table 2.

The patient’s diagnostic and treatment process in chronological order

2007 2007–2015 April-October 2015 October 2015-February 2016 December 2015-January 2016
First diagnosis of GPA diagnosed by glomerulon ephritis Permanent medication with prednisolone and cyclosporine. Development of a steroid-associated osteoporosis treated intravenously with denosumad. Over the time developing pulmonary emphysema, Raynaud’s phenomenon, sinusitis maxilliaris and orbital pseudotumor. Development of gingival hyperlpasia. In the following periodontal theraphy without benefit by her dentist. Thus reffered to periodontist. Recommendation for gingivectomy, transfer to Department of Cranio-Maxillofacial Surgery, University Hospital Münster. Biospsy from hyperplastic gingivitis taken Ambulant follow-up in the Department of Cranio-Maxillofacial Surgery, University Hospital Münster. Suspiction of recurrence of GPA by increasing (c)-ANCA and clinical signs of recurrence. Stationary therapie at Internal Medicine Clinic, University Hospital Münster. In the following 375 mg/m2 rituximab weekly for a total of 4 doses, and prednisolone 10 mg/day.